A systematic approach to the consensus definitions and reliability of ultrasound in idiopathic inflammatory myopathies; Preliminary data by the OMERACT ultrasound working group in myositis

Shereen Paramalingam

doi:10.1016/j.semarthrit.2026.152984

Superior drug retention of selective JAK1 inhibitors compared to pan-JAK inhibitors in rheumatoid arthritis: A meta-analysis of real-world evidence

2026-04-21

0

PRE

AI

Y

Young Ho Lee *

G

Gwan Gyu Song

DOI：10.1016/j.semarthrit.2026.152989

Original

Original request for help

Save

Abstract

En 中文

The durability of Janus kinase (JAK) inhibitors in routine clinical practice is still debated. This study aimed to compare the drug retention rates of selective JAK1 inhibitors (upadacitinib, filgotinib) with pan-JAK inhibitors (tofacitinib, baricitinib) in patients with rheumatoid arthritis (RA) using real-world data.

Keywords:

JAK inhibitors

JAK1 inhibitors

pan-JAK inhibitors

rheumatoid arthritis

drug retention

Superior drug retention of selective JAK1 inhibitors compared to pan-JAK inhibitors in rheumatoid arthritis: A meta-analysis of real-world evidence

Abstract

Journal

Organization

Cited Papers

Citing Papers